Market Research Logo

Global Travel Vaccines Market 2018-2022

Global Travel Vaccines Market 2018-2022

About this market

Increased incidence of travel-related diseases is expected to drive the market growth. Traveling is often associated with higher health risks especially regarding infectious diseases. Thus, the rising incidence of travel related diseases will lead to more investments in the global travel vaccines market for the development of more effective vaccines. Technavio’s analysts have predicted that the travel vaccines market will register a CAGR of almost 10% by 2022.

Market Overview

Increase in global travel and migration

With the rise in traveling over the past few years has resulted in the spread of pathogens and disease-causing vectors worldwide. The increase in travel and migration offers huge opportunities to the manufacturers to invest in the R&D of new and more effective vaccines.

High cost of travel vaccinations

Travel clinics offer vaccinations at a slightly higher price and new vaccines are usually more expensive.

For the detailed list of factors that will drive and challenge the growth of the travel vaccines market during the 2019-2023, view our report.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies including Sanofi and Valneva the competitive environment is quite intense. Factors such as the increased incidence of travel-related diseases and the increase in global travel and migration, will provide considerable growth opportunities to travel vaccines manufactures. GlaxoSmithKline, Pfizer, Sanofi, and Valneva are some of the major companies covered in this report.


  • Executive summary
  • Scope of the report
  • Research methodology
  • Market landscape
    • Market ecosystem
      • Table Parent market
      • Table Global human vaccines market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Pipeline analysis
    • Table Pipeline Vaccines Under Phase III Development
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2017
      • Table Market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast 2017-2022
      • Table Global - Market size and forecast 2017-2022 ($ mn)
      • Table Global - Year-over-year growth 2018-2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2017
  • Market segmentation by target disease for immunization
    • Segmentation by target disease for immunization
      • Table Target disease for immunization - Market share 2017-2022 (%)
    • Comparison by target disease for immunization
      • Table Comparison by target disease for immunization
    • Influenza - Market size and forecast 2017-2022
      • Table Influenza - Market size and forecast 2017-2022 ($ mn)
      • Table Influenza - Year-over-year growth 2018-2022 (%)
    • Diphtheria - Market size and forecast 2017-2022
      • Table Diphtheria - Market size and forecast 2017-2022 ($ mn)
      • Table Diphtheria - Year-over-year growth 2018-2022 (%)
    • Others - Market size and forecast 2017-2022
      • Table Others - Market size and forecast 2017-2022 ($ mn)
      • Table Others - Year-over-year growth 2018-2022 (%)
    • Hepatitis - Market size and forecast 2017-2022
      • Table Hepatitis - Market size and forecast 2017-2022 ($ mn)
      • Table Hepatitis - Year-over-year growth 2018-2022 (%)
    • Typhoid - Market size and forecast 2017-2022
      • Table Typhoid - Market size and forecast 2017-2022 ($ mn)
      • Table Typhoid - Year-over-year growth 2018-2022 (%)
    • Polio - Market size and forecast 2017-2022
      • Table Polio - Market size and forecast 2017-2022 ($ mn)
      • Table Polio - Year-over-year growth 2018-2022 (%)
    • Yellow fever - Market size and forecast 2017- 2022
      • Table Yellow fever - Market size and forecast 2017-2022 ($ mn)
      • Table Yellow fever - Year-over-year growth 2018-2022 (%)
    • Market opportunity by target disease
      • Table Market opportunity by target disease for immunization
  • Customer landscape
    • Table Customer landscape
  • Regional landscape
    • Geographical segmentation
      • Table Global - Market share by geography 2017-2022 (%)
    • Regional comparison
      • Table Regional comparison
    • Americas - Market size and forecast 2017-2022
      • Table Americas - Market size and forecast 2017-2022 ($ mn)
      • Table Americas - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in Americas
    • EMEA - Market size and forecast 2017-2022
      • Table EMEA - Market size and forecast 2017-2022 ($ mn)
      • Table EMEA - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in EMEA
    • APAC - Market size and forecast 2017-2022
      • Table APAC - Market size and forecast 2017-2022 ($ mn)
      • Table APAC - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in APAC
    • Market opportunity by region
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
  • Market trends
    • Changes in the demographic profile of travelers globally
    • Increased incidence of travel-related diseases
    • Initiatives by governments and other organizations to ensure travel safety
    • Evolving epidemiological patterns of infectious diseases in different countries
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • GlaxoSmithKline
      • Table GlaxoSmithKline - Overview
      • Table GlaxoSmithKline - Business segments
      • Table GlaxoSmithKline - Organizational developments
      • Table GlaxoSmithKline - Geographic focus
      • Table GlaxoSmithKline - Segment focus
      • Table GlaxoSmithKline - Key offerings
    • Pfizer
      • Table Pfizer - Overview
      • Table Pfizer - Business segments
      • Table Pfizer - Organizational developments
      • Table Pfizer - Geographic focus
      • Table Pfizer - Segment focus
      • Table Pfizer - Key offerings
    • Sanofi
      • Table Sanofi - Overview
      • Table Sanofi - Business segments
      • Table Sanofi - Organizational developments
      • Table Sanofi - Geographic focus
      • Table Sanofi - Segment focus
      • Table Sanofi - Key offerings
    • Valneva
      • Table Valneva - Overview
      • Table Valneva - Business segments
      • Table Valneva - Organizational developments
      • Table Valneva - Geographic focus
      • Table Valneva - Key offerings
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report